The Bulletin
The Times


.

Kazia Therapeutics Regains Full Nasdaq Listing Compliance

  • Written by PR Newswire

Restoration of Nasdaq compliance follows $50 million institutional financing and reinforces balance-sheet strength

SYDNEY, Dec. 22, 2025 /PRNewswire/ -- Kazia Therapeutics Limited ("Kazia" or the "Company") (NASDAQ: KZIA), a clinical-stage oncology company focused on developing innovative therapies for cancer, today announced that it has regained...

hacklink hack forum hacklink film izle hacklink grandpashabetgrandpashabetz library frDeneme bonusu veren siteler 2026Deneme bonusu veren siteler 2026Grandpashabetmarsbahis girişbahiscasinobetparkaresbetmarsbahisbahiscasinograndpashabetmarsbahispashagaming girişjojobetcasibomholiganbetcasibomjojobetjojobetcasino siteleriGrandpashabetjojobetjojobetjojobetholiganbetcasibomgrandpashabet